Senhance

Shares of Transenterix Inc (NYSE: TRXC), a small-cap medical device company, gained 11 percent Monday morning after confirming an asset sale. What You Need To Know Transenterix confirmed it has agreed to sell its Senhance Surgical Robotic System to Florida Hospital, a member of Adventist Health...

Transenterix Inc (NYSE: TRXC) investors were thrilled when the company’s Senhance system secured the first U.S. approval for abdominal surgical robotics in nearly two decades. And as Stifel Nicolaus found, excitement wasn’t exclusive to shareholders. “Surgeon interest in Senhance...

Shares of medical device company Transenterix Inc (NYSE: TRXC), which specializes in making surgical robots, took a tumble after short seller TheStreetSweeper released a report saying sell the stock. At time of writing, shares of TransEnterix were off 9.65 percent at $2.81. The shares were...

Transenterix Inc (NYSE: TRXC) stock has exploded higher on incredible volume over the past two days after the company gained FDA clearance for its Senhance surgical robot. The clearance is certainly good fundamental news for the company, but the stock’s meteoric 200 percent two-day gain...

Transenterix Inc (NYSE: TRXC) stock is up more than 56 percent Monday after the company gained FDA clearance for its Senhance surgical robot. The company was previously denied clearance from the FDA for its SurgiBot System back in April 2016. According to the company, Senhance is now the first new...